Generate a tailored SOP for Dr. Benjamin Ebert. Improve your application with a focused, well-structured draft.
Benjamin Ebert is the Jean S. Canellos Professor of Medicine at Harvard Medical School and the Chair of Medical Oncology at Dana-Farber Cancer Institute. He is also an Investigator for the Howard Hughes Medical Institute and an Institute Member at the Broad Institute. His research is focused on the molecular basis of treatment for hematologic malignancies, specifically myelodysplastic syndromes (MDS). His lab has conducted large-scale genetic analyses of patient samples, identifying somatic mutations that predict prognosis and response to therapies in MDS patients. Ebert's work examines the pre-malignant state of hematologic cancers, particularly clonal hematopoiesis of indeterminate potential (CHIP), which increases cardiovascular disease risk. His lab studies the biological mechanisms underlying the transformation of hematopoietic cells by specific somatic mutations, including the elucidation of the mechanism of action of lenalidomide, a thalidomide derivative.
Administered by the Division of Medical Sciences (DMS). GRE is not required and will not be considered for BBS, Immunology, and Neuroscience.